Novartis experimental actinium-based drug shows promise in prostate cancer treatment: StudyNovartis' new experimental actinium-based drug shows promise against prostate cancer. Early data on Sunday revealed anti-tumour activity, e...
31 May, 2026, 05.00 PM IST
These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsHas a peace deal been agreed on by the US and Iran? Will the fragile ceasefire hold? No one can answer these questions with any certainty. ...
28 May, 2026, 11.04 PM IST
Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
23 May, 2026, 10.24 PM IST
Alembic Pharma gets USFDA tentative nod for generic prostate cancer drugAlembic Pharmaceuticals has secured tentative approval from the USFDA for its generic version of Darolutamide tablets, targeting prostate c...
14 May, 2026, 04.32 PM IST
Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
29 Apr, 2026, 02.22 PM IST
US judge rejects Bayer bid to block Johnson & Johnson prostate cancer drug claimsA US judge has dismissed Bayer's plea to halt Johnson & Johnson's advertising for its prostate cancer drug Erleada. Bayer alleged false cla...
18 Apr, 2026, 07.54 AM IST
AstraZeneca Pharma India surrenders marketing authorisation of prostate cancer drugAstraZeneca Pharma India has voluntarily surrendered the marketing authorisation for its prostate cancer drug Olaparib (Lynparza) 100mg and...
15 Apr, 2025, 01.48 PM IST
Zydus launches pill for prostate cancer patientsThe drug firm said the medication would cost Rs 6,995 per month, which is 50 per cent less than the currently available injectable options....
30 Jan, 2024, 04.51 PM IST
BDR Pharmaceuticals introduces prostate cancer treatment drug in oral solution formIt is a more patient-friendly way to tackle prostate cancer. It can help improve patient compliance to a great extent, Badiger said. The co...
02 Jan, 2024, 02.09 PM IST
BDR Pharmaceutical launches generic drug for treating prostate cancer in IndiaBDR Group Director Business Development Raheel Shah said that the launch of APATIDE is "testimony towards our commitment in providing acces...
03 Jan, 2023, 03.33 PM IST
'Can treat tumors that you cannot see'. Radiation drugs hunt & kill cancer cells, says new studyThe drug in this case is a molecule that contains two parts: a tracker and a cancer-killing payload.
04 Jun, 2021, 03.57 PM IST
IIT researchers find new molecule that can be used as targeted therapy to treat prostate cancerThe molecule has shown potency in cells to completely reduce tumour in 50 days.
30 Sep, 2020, 01.10 PM IST
BDR Pharma launches 80 mg version of prostate cancer drug at Rs 24,480 per pack in IndiaThe company had earlier received approval from the Drugs Controller General of India (DCGI) to manufacture 40 mg enzalutamide in 2017 to tr...
21 Sep, 2020, 03.45 PM IST
Zydus Cadila launches generic prostate cancer drug at nearly 70% less price in India"Our aim is to make a preferred choice of therapy like Obynx available and more accessible to people suffering from cancer. Bridging these ...
08 May, 2020, 03.44 PM IST
New 3-in-1 blood test can transform the treatment of advanced prostate cancerThe test could help to extend or save lives, by targeting treatment more effectively.
19 Jun, 2017, 01.16 PM IST
- 'Repurposing' malaria drug to treat castrate-resistant prostate cancer
Kolkata, March 26 (IANS) Tapping into the trend of repurposing old approved drugs to treat totally different diseases -- a strategy that le...
26 Mar, 2017, 12.40 PM IST
Panacea launches prostate cancer drugDrug firm Panacea Biotec today launched Cabapan injection, an indigenously developed drug for treating prostate cancer.
28 Mar, 2016, 01.10 PM IST